市場概況

The clinical trials software market is projected to grow at a CAGR of 11.5% から 2023 に 2029, reaching a value of $2.33 10億まで 2029, up from $1.05 億で 2022. Clinical trials play a vital role in disease treatment and improving detection, 診断, and prevention. The market’s growth is driven by pharmaceutical organizations’ cost reduction demands and technology advancements. Clinical trial software (CTMS) helps manage research activities for contract research organizations (CRO). The global increase in clinical trials necessitates software solutions for easy access to activities. The biopharmaceutical industry has seen changes, with CROs becoming integral to clinical trial services. CTMS streamlines the process. The COVID-19 pandemic accelerated the digitization of trials, leading to increased adoption of digital tools and remote monitoring devices. Cloud computing offers opportunities for market vendors. Virtual trials gain traction with software enabling increased patient enrollment. Virtual patient recruitment software eliminates travel, automates data collection, and enhances engagement. Key players prefer unified platforms. Medidata offers a comprehensive unified platform. IQVIA is a leading pharmaceutical company in cloud computing. Digital tools address cost and timeline challenges. The pandemic prompted software use for vaccine production and trials.

レポートは市場規模と成長をカバーしています, セグメンテーション, 競争環境, trends and strategies for global clinical trials software market. 利害関係者が現在の市場機会を活用できるように、市場の定量的な分析を提供します。. このレポートはまた、市場動向と主要な競合他社のアプローチに基づいて、機会と戦略の上位セグメントを特定します。.

市場セグメンテーション

The market is segmented based on various factors, including deployment, delivery, feature, エンドユーザー, そして地理.
Deployment: on-enterprises, 現場で
Delivery: ウェブベースの, SaaS, オンプレミス
Feature: EDC, eCOA/ePRO, eConsent
エンドユーザー: CRO, bio-pharmaceutical companies, medical device manufacturers, その他

Segmentation by Geography
North America – US, カナダ
Europe – Germany, フランス, イギリス, イタリア, スペイン
APAC – 中国, 日本, インド, 韓国, オーストラリア
Latin America – Brazil, メキシコ, アルゼンチン
中東 & Africa – South Africa, サウジアラビア, 七面鳥, UAE

The clinical trial software market is divided into on-enterprises and on-site segments. の 2022, on-enterprises held the dominant position, accounting for 78.6% of the market. This is due to the increasing adoption of technology in biopharmaceutical companies and the usage of clinical trial management systems. On-site deployment offers advantages to contracting research organizations, sponsors, and academic and government institutes. Biopharmaceutical companies with their own IT infrastructure find it easier to handle CTMS solutions, reducing costs and timelines.

Web-based delivery was the dominant segment in 2022, accounting for 44.5% of the market share. Major biopharmaceuticals prefer web-based delivery for seamless data management, 分析, medical writing, and regulatory submission. It enables quick reviews and efficient data collection from participants through internet platforms, reducing errors and confusion. The increasing competitiveness in the biopharma and contract research industries drives the demand for software. Web-based delivery provides faster delivery and is associated with the acceptance of Software-as-a-Service (SaaS) in CTMS.

The global clinical trials software market is further segmented into EDC, eCOA/ePRO, and eConsent. EDC, also known as eCRF, is vital for collecting and analyzing patient data. The increasing demand for participant data and the use of EDC contribute to significant market growth, with a share of 46.6% で 2022.

CROs accounted for 45.7% of the market share in 2022. They experience high demand for medical research from biopharmaceutical companies, medical device manufacturers, and other authorities. Intense competition, high investments, and low success rates of clinical trials drive the demand for CROs.

North America has the largest market share, と 34.3% で 2022. This is due to the presence of key market players, a high number of biopharmaceutical companies, and significant research and development expenditure in the region.

競争環境

The global clinical trial software market is highly competitive due to collaboration, cloud-based platforms, and new solutions. Regional companies in Europe, APAC, and North America are investing in advanced software products, posing a threat to global players. This creates growth opportunities for existing and emerging players. Key companies profiled include Advarra, 株式会社, ArisGlobal LLC, Axiom Real-Time Metrics Inc., BSI Business Systems Integration AG, Ciwit B.V. (Castor), Clario, 株式会社, ClinCapture , 株式会社, Dassault Systemes SE, Datatrak International, 株式会社. (Fountayn LLC), Datatrial Limited, Dotmatics Limited (Statsols), Florence Healthcare, 株式会社, Fortress Medical Systems, LLC, アイ・ビー・エム株式会社, IQVIA Holdings, 株式会社, Labcorp Drug Development Inc., Medrio, 株式会社, Oracle Corporation, PAREXEL International Corporation, Reify Health, 株式会社, Veeva Systems Inc., とりわけ.

報告書の範囲

To analyze and forecast the market size of the global clinical trials software market.
To classify and forecast the global clinical trials software market based on deployment, delivery, feature, エンドユーザー, 地理.
To identify drivers and challenges for the global clinical trials software market.
合併などの競争展開を検討するため & 買収, 協定, コラボレーションとパートナーシップ, 等, in the global clinical trials software market.
To identify and analyze the profile of leading players operating in the global clinical trials software market.

このレポートを選択する理由

Gain a reliable outlook of the global clinical trials software market forecasts from 2023 に 2029 シナリオ全体にわたって.
投資対象となる成長セグメントを特定する.
会社概要と市場データを通じて競合他社に先んじる.
Excel 形式でのシナリオ全体の分析を容易にするための市場予測.
3ヶ月間の戦略コンサルティングとリサーチサポート.
シングルユーザーライセンスに提供される印刷認証.